Intravascular stenting in congenital heart disease (CHD) is a treatment modality that must account for patient somatic growth and future re-intervention. Stent expansion and intentional fracture can be performed safely and effectively. Limited understanding and data exist for drug-eluting coronary stents (DES).
View Article and Find Full Text PDFJ Soc Cardiovasc Angiogr Interv
February 2025
Background: Technical success (TS) and procedural safety (PS) have been reported individually for transcatheter atrial septal defect (ASD) and patent ductus arteriosus (PDA) closures. A composite procedural performance (PP) metric as a patient-centered strategy has not been developed or studied.
Methods: A multicenter expert working group created PP metrics for ASD and PDA device closures as a composite of TS and PS.
We describe the use of a total artificial heart (TAH) (Syncardia) as a successful bridge to transplantation in a pediatric patient. The post-TAH course included obstruction of both systemic veins with decreased TAH filling and output that was successfully treated with bicaval stent placement. After stenting of the systemic veins, the patient was able to successfully rehabilitate and underwent successful cardiac repeated transplantation 6 months after TAH placement.
View Article and Find Full Text PDFBackground: Covered stent correction for a sinus venosus atrial septal defect (SVASD) was first performed in 2009. This innovative approach was initially viewed as experimental and was reserved for highly selected patients with unusual anatomic variants. In 2016, increasing numbers of procedures began to be performed, and in several centers, it is now offered as a standard of care option alongside surgical repair.
View Article and Find Full Text PDFJ Soc Cardiovasc Angiogr Interv
October 2023
Background: Safety events and technical success (TS) have been previously reported for aortic and pulmonary valvuloplasty, but a composite performance measure as a novel, patient-centered strategy has neither been developed nor been studied. This study aims to refine a procedural performance (PP) variable, a composite of TS and procedural safety, for isolated, standard-risk aortic and pulmonary valvuloplasty.
Methods: A multicenter review was performed using data from the Congenital Cardiac Catheterization Project on Outcomes registry.
J Invasive Cardiol
September 2024
Pulmonary vein stenosis (PVS) in children is a challenging condition with poor outcomes. Post-operative stenosis can occur after repair of anomalous pulmonary venous return (APVR) or stenosis within native veins. There is limited data on the outcomes of post-operative PVS.
View Article and Find Full Text PDFJ Thorac Cardiovasc Surg
October 2023
J Am Soc Echocardiogr
June 2023
World J Pediatr Congenit Heart Surg
November 2022
Introduction: Pulmonary atresia with the ventricular septal defect is a rare congenital heart defect with high anatomic variability. The most important management question relates to the sources of pulmonary blood flow. The ability to differentiate between ductal dependence and major aortopulmonary collateral arteries is critical to achieving good outcomes and avoiding life-threatening hypoxia in the postneonatal period.
View Article and Find Full Text PDFBackground: Percutaneous transcatheter pulmonary valve replacement (TPVR) has good clinical and hemodynamic outcomes in treating dysfunctional bioprosthetic valves (BPV) in the pulmonary position. Valve-in-valve therapy can further decrease the inner diameter (ID), potentially resulting in patient-prosthesis mismatch in patients with smaller BPVs.
Methods And Results: To evaluate feasibility and outcomes of intentional BPV fracture to enlarge the pulmonary valve orifice with TPVR, 37 patients from 13 centers who underwent TPVR with intended BPV fracture were evaluated.
Transcatheter stent implantation for SVC obstruction following OHT has been well described, particularly in pediatric patients. This study describes a large single-center pediatric heart transplant experience that investigates the risk factors for SVC stenosis requiring stent implantation and its associated outcomes. All pediatric OHTs between January 1, 2000, and December 12, 2016, were examined for risk factors.
View Article and Find Full Text PDFSemin Thorac Cardiovasc Surg
November 2018
Balloon-expandable stents, implanted in infants and children with congenital heart disease (CHD), often require redilation to match somatic growth. Small diameter stents may eventually require longitudinal surgical transection to prevent iatrogenic vascular stenosis. Intentional transcatheter stent fracture (TSF) is an emerging alternative approach to stent transection, but little is known about the optimal stent substrate and best protocol to improve the likelihood of successful TSF.
View Article and Find Full Text PDFA 20-month-old boy with Williams syndrome had undergone multiple surgical and catheter-based interventions for resistant peripheral pulmonary arterial stenoses with eventual bilateral stent placement and conventional balloon angioplasty. He persistently developed suprasystemic right ventricular (RV) pressure. Angioplasty with a drug-coated balloon (DCB) was performed for in-stent restenosis and to remodel his distal pulmonary vessels bilaterally.
View Article and Find Full Text PDFObjective: Intravascular stents are now routinely used to treat young patients with vascular stenoses. Future stent redilations are often necessary to account for somatic growth. The purpose of this study was to compile a database of characteristics for stents commonly used in the treatment of congenital heart disease patients, and compare serial dilation to direct dilation to the maximal diameter.
View Article and Find Full Text PDF